Possible roles of human (pro)renin receptor suggested by recent clinical and experimental findings

Hypertension Research

Volumn 33, Issue 3, 2010, Pages 177-180

  Ichihara, Atsuhiro ^a   Sakoda, Mariyo ^a   Kurauchi Mito, Asako ^a   Narita, Tatsuya ^a   Kinouchi, Kenichiro ^a   Murohashi Bokuda, Kanako ^a   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin; ATP6ap2; Handle region peptide; Prorenin; Vacuolar H + ATPase

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 1BETA; PRORENIN; PRORENIN RECEPTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; RENIN; TUMOR NECROSIS FACTOR ALPHA;

BLOOD PRESSURE REGULATION; CHROMOSOME XP; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GLOMERULOSCLEROSIS; HEART FAILURE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PROTEINURIA; REVIEW; TRANS GOLGI NETWORK;

ANIMALS; CHRONIC DISEASE; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; KIDNEY DISEASES; MICE; MICE, KNOCKOUT; RATS; RATS, INBRED SHR; RECEPTORS, CELL SURFACE; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 77749239824     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.214     Document Type: Review

References (35)

1. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer J-D. Pivotal role of the renin/ prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109: 1417-1427.
2. Batenburg WW, Krop MK, Garrelds IM, deVries R, deBruin RJA, Burckle CA, Muller DN, Bader M, Nguyen G, Danser AHJ. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens 2007; 25: 2441-2453.
3. Nabi AHMN, Uddin M, Nakagawa T, Iwata H, Ichihara A, Inagami T, Suzuki F. Role of 'handle' region of prorenin prosegment in the non-proteolytic activation of prorenin by binding to membrane anchored (pro)renin receptor. Front Biosci 2007; 12: 4810-4817.
4. Huang Y, Noble N, Zhang J, Xu C, Border W. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int 2007; 72: 42-52.
5. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, Noble NA, Border W. Renin increases mesangial cell transforming growth factor-b1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 2006; 69: 105-113.
6. He M, Zhang L, Shao Y, Wang X, Huang Y, Yao T, Lu L. Inhibition of renin/prorenin receptor attenuated mesangial cell proliferation and reduced associated fibrotic factor release. Eur J Pharmacol 2009; 606: 155-161.
7. Sakoda M, Ichihara A, Kaneshiro Y, Takemitsu T, Nakazato Y, Migita T, Nabi AHMN, Nakagawa T, Suzuki F, Inagami T, Itoh H. The (pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells. Hypertens Res 2007; 30: 1139-1146.
8. Saris J, 'tHoen P, Garrelds I, Dekkers D, denDunnen J, Lamers J, JanDanser A. Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension 2006; 48: 564-571.
9. Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, Thai K, Connelly KA, Yuen D, Trogadis J, Herzenberg AM, Kuliszewski MA, Leong-Poi H, Gilbert RE. The (pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension 2009; 54: 261-269.
10. Suzuki F, Hayakawa M, Nakagawa T, Nasir UM, Ebihara A, Iwasawa A, Ishida Y, Nakamura Y, Murakami K. Human prorenin has 'gate and handle' regions for its non-proteolytic activation. J Biol Chem 2003; 278: 22217-22222.
11. Nabi AHMN, Biswas KB, Nakagawa T, Ichihara A, Inagami T, Suzuki F. 'Decoy peptide' region (RIFLKRMPSI) of prorenin prosegment plays a crucial role in prorenin binding to the (pro)renin receptor. Int J Mol Med 2009; 24: 83-89.
12. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi AHMN, Ishida Y, Inagami T, Saruta T. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the 'handle' region for non-proteolytic activation of prorenin. J Clin Invest 2004; 114: 1128-1135.
13. Siragy HM, Huang J. Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol 2008; 93: 709-714.
14. Matavelli LC, Huang J, Siragy HM. (Pro)renin receptor contributes to diabetic nephro-pathy through enhancing renal inflammation. Clin Exp Pharmacol Physiol 2009 (e-pub ahead of print 21 September 2009; PMID: 19769609).
15. Takahashi H, Ichihara A, Kaneshiro Y, Inomata K, Sakoda M, Takemitsu T, Nishiyama A, Itoh H. Regression of nephropathy developed in diabetes by (pro)renin receptor blockade. J Am Soc Nephrol 2007; 18: 2054-2061.
16. Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, Takemitsu T, Sakoda M, Nabi AHMN, Nishiyama A, Sugaya T, Hayashi M, Inagami T. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor deficient mice. J Am Soc Nephrol 2006; 17: 1950-1961.
17. Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, Tsubota K, Itoh H, Oike Y, Ishida S. (Pro)renin receptor-mediated signal transduction and tissue renin-angio-tensin system contribute to diabetes-induced retinal inflammation. Diabetes 2009; 58: 1625-1633.
18. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Nakagawa T, Nishiyama A, Kawachi H, Shimizu F, Inagami T. Contribution of non-proteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 2006; 17: 2495-2503.
19. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, Nishiyama A, Inagami T, Hayashi M. Non-proteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006; 47: 894-900.
20. Susic D, Zhou X, Frohlich ED, Lippton H, Knight M. Cardiovascular effects of prorenin blockade in genetically hypertensive rats (SHR) on normal and high salt diet. Am J Physiol Heart Circ Physiol 2008; 295: H1117-H1121.
21. Muller DN, Klanke B, Feldt S, Cordasic N, Hartner A, Schmieder RE, Luft FC, Hilgers KF. (Pro)renin receptor peptide inhibitor 'handle-region' peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension 2008; 51: 676-681.
22. Feldt S, Maschke U, Dechend R, Luft FC, Muller DN. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol 2008; 19: 743-748.
23. Nabi AHMN, Kageshima A, Uddin M, Nakagawa T, Park E, Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med 2006; 18: 483-488.
24. Peters B, Grisk O, Becher B, Wanka H, Kuttler B, Ludemann J, Lorenz G, Rettig R, Mullins JJ, Peters J. Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis. J Hypertens 2008; 26: 102-109.
25. Mercure C, Prescott G, Lacombe M-J, Silversides DW, Reudelhuber TL. Chronic increases in circulating prorenin are not associated with renal or cardiac pathologies. Hypertension 2009; 53: 1062-1069.
26. Schefe J, Menk M, Reinemund J, Effertz K, Hobbs R, Pandolfi P, Ruiz P, Unger T, Funke-Kaiser H. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 2006; 99: 1355-1366.
27. Schefe JH, Neumann C, Goebel M, Danser J, Kirsch S, Gust R, Kintscher U, Unger T, Funke-Kaiser H. Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. J Hypertens 2008; 26: 1787-1795.
28. Krebs C, Hamming I, Sadaghiani S, Steinmetz OM, Meyer-Schwesinger C, Fehr S, Stahl RAK, Garrelds IM, Danser AHJ, Goor Hv, Contrepas A, Nguyen G, Wenzel U. Anti-hypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney Int 2007; 72: 725-730.
29. Hirose T, Mori N, Totsune K, Morimoto R, Maejima T, Kawamura T, Metoki H, Asayama K, Kikuya M, Ohkubo T, Kohzuki M, Takahashi K, Imai Y. Gene expression of (pro)renin receptor is upregulated in hearts and kidneys of rats with congestive heart failure. Peptides 2009; 30: 2316-2322.
30. Perola M, Kainulainen K, Pajukanta P, Terwilliger JD, Hiekkalinna T, Ellonen P, Kaprio J, Koskenvuo M, Kontula K, Peltonen L. Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings. J Hypertens 2000; 18: 1579-1585.
31. Hirose T, Hashimoto M, Totsune K, Metoki H, Asayama K, Kikuya M, Sugimoto K, Katsuya T, Ohkubo T, Hashimoto J, Rakugi H, Takahashi K, Imai Y. Association of (pro)renin receptor gene polymorphism with blood pressure in Japanese men: the Ohasama study. Am J Hypertens 2009; 22: 294-299.
32. Takemitsu T, Ichihara A, Kaneshiro Y, Sakoda M, Kurauchi-Mito A, Narita T, Kinouchi K, Yamashita N, Itoh H. Association of (pro)renin receptor mRNA expression with angiotensin-converting enzyme mRNA expression in human artery. Am J Nephrol 2009; 30: 361-370.
33. Cousin C, Bracquart D, Contrepas A, Corvol P, Muller L, Nguyen F. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension 2009; 53: 1077-1082.
34. Ludwig J, Kerscher S, Brandt U, Pfeiffer K, Getlawi F, Apps DK, Schagger H. Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J Biol Chem 1998; 273: 10939-10947.
35. Paroutis P, Touret N, Grinstein S. The pH of the secretory pathway: measurement, determinants, and regulation. Physiology 2004; 19: 207-215.